Výsledky vyhledávání - "Anita Compan"

Akademický článek

Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy

Autor: Lenche Kostadinova, Carey L. Shive, Elizabeth Zebrowski, Brianna Fuller, Kelsey Rife, Amy Hirsch, Anita Compan, Anita Moreland, Yngve Falck-Ytter, Daniel L. Popkin, Donald D. Anthony

Publikováno v: Pathogens and Immunity, Vol 3, Iss 1, Pp 149-163 (2018)

Background: During chronic hepatitis C virus (HCV) infection, Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) levels mark active liver inflammation and tissue damage, while albumin reflects synthetic liver function and nutritional

Externí odkaz: https://doaj.org/article/a651cb373a704c528bb45bc7a62bed87

Zobrazit plný text záznamu

Akademický článek

Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.

Autor: Perica Davitkov, Apoorva Krishna Chandar, Amy Hirsch, Anita Compan, Marina G Silveira, Donald D Anthony, Suzanne Smith, Clare Gideon, Robert A Bonomo, Yngve Falck-Ytter

Publikováno v: PLoS ONE, Vol 11, Iss 10, p e0163945 (2016)

Clinicians often face dilemmas with decisions related to formulary choices when two similar drugs are simultaneously available in the market. We studied the comparative safety, effectiveness, and treatment costs of the two first generation direct-act

Externí odkaz: https://doaj.org/article/e0b28ffe2d2742a7978d941a3ceda23c

Zobrazit plný text záznamu

During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy

Autor: Kelsey Rife, Donald D. Anthony, Carey L. Shive, Xiaolin Li, Mark R. Chance, Chelsey J. Judge, Elizabeth Zebrowski, Daniela Schlatzer, Lenche Kostadinova, Daniel L. Popkin, Anita Compan, Amy Hirsch, Benigno Rodriguez, Yngve Falck-Ytter

Publikováno v: Journal of Infectious Diseases. 214:1438-1448

BACKGROUND Immune activation predicts morbidity during hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) infection, although mechanisms underlying immune activation are unclear. Plasma levels of autotaxin and its enzymatic prod

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d284614a8841521fe4c3b342b73389f5
https://doi.org/10.1093/infdis/jiw372

Zobrazit plný text záznamu

Genetically Associated CD16+56− Natural Killer Cell Interferon (IFN)–αR Expression Regulates Signaling and Is Implicated in IFN-α–Induced Hepatitis C Virus Decline

Autor: Nicole L. Yonkers, Gareth Hardy, Sara J. Conry, Donald D. Anthony, Perica Davitkov, Clifford V. Harding, Anita Compan, Qinglai Meng, Amy Hirsch, Benigno Rodriguez, Ronald E. Blanton, Julia M. Sugalski, Yngve Falck-Ytter

Publikováno v: The Journal of Infectious Diseases. 205:1131-1141

Acute hepatitis C virus (HCV) infection becomes persistent in a majority of cases [1], and the long-term risk of cirrhosis, liver failure, cancer, and mortality among those with chronic infection highlight the importance of effective therapy [1, 2].

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05513f30ef980d0d68161c10f7444e01
https://doi.org/10.1093/infdis/jis027

Zobrazit plný text záznamu

No Significant Differences in SVR Rates for African Americans (AA) vs. Non-AA with an 8 Week Treatment Course of Ledipasvir/Sofosbuvir (LDV/SOF) in HCV

Autor: Yasser Alsamman, Amy Hirsch, Christina Vonhaz, Kelsey Rife, Yngve Falck-Ytter, Anita Compan, Perica Davitkov, Vanessa Marshall

Publikováno v: Gastroenterology. 152:S1093

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::255f374754b5f7eddc2ef492d08dccb0
https://doi.org/10.1016/s0016-5085(17)33682-x

Zobrazit plný text záznamu

Appropriately Managed Proton Pump Inhibitor (PPI) Use does not Reduce Sustained Virologic Response with Ledipasvir/Sofosbuvir (LDV/SOF)

Autor: Christina Vonhaz, Yngve Falck-Ytter, Kelsey Rife, Amy Hirsch, Vanessa Marshall, Kierra M. Dotson, Perica Davitkov, Anita Compan, Yasser Alsamman

Publikováno v: Gastroenterology. 152:S1091

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::674d2280eb85f8208548580822bca06e
https://doi.org/10.1016/s0016-5085(17)33677-6

Zobrazit plný text záznamu

Su1421 Impact of Proton Pump Inhibitors on Achieving SVR from 8 Week Course of Ledipasvir/Sofosbuvir

Autor: Anita L. Moreland, Yngve Falck-Ytter, Marina Rodrigues Garcia da Silveira, Amy Hirsch, Kelsey Rife, Anita Compan, Vanessa Marshall

Publikováno v: Gastroenterology. 150:S1095

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::725df7022f287f2d36811adc7e5b5d88
https://doi.org/10.1016/s0016-5085(16)33698-8

Zobrazit plný text záznamu

Su1075 Boceprevir -Associated Resource Use Is Less Per SVR Achieved Compared to Telaprevir -A Pragmatic Head-to-Head Randomized Controlled Trial

Autor: Perica Davitkov, Robert A. Bonomo, Donald D. Anthony, Yngve Falck-Ytter, Apoorva K. Chandar, Amy Hirsch, Marina G. Silveira, Anita Compan

Publikováno v: Gastroenterology. 146:S-982

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b5abbc879eb999afb9e451dbf738c007
https://doi.org/10.1016/s0016-5085(14)63566-6

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání